This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire Vaudois (c.h.u.v.), Consejo Superior De Investigaciones Cientificas. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Faustino Mollinedo: Innovator in Cancer Treatment
Introduction
Faustino Mollinedo is a notable inventor based in Galapagar, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective therapies for pancreatic cancer, a disease that poses significant challenges in medical treatment.
Latest Patents
Mollinedo holds a patent for "Piperidine derivatives for use in the treatment of pancreatic cancer." This invention relates to novel piperidine derivatives that exhibit enhanced cell growth inhibitory activities against cancer cell cultures, particularly PANC-1 cancer cell cultures, compared to existing treatments like FK866. The compounds described in his patent possess valuable pharmacological properties and have shown potential as chemotherapeutic agents against pancreatic cancers.
Career Highlights
Throughout his career, Faustino Mollinedo has worked with prestigious institutions, including the Centre Hospitalier Universitaire Vaudois and the Consejo Superior de Investigaciones Científicas. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mollinedo has collaborated with notable colleagues such as Pierre Vogel and Michel Duchosal. These partnerships have enriched his research and facilitated the development of innovative cancer treatments.
Conclusion
Faustino Mollinedo's contributions to cancer research, particularly in the development of piperidine derivatives, highlight his commitment to improving therapeutic options for pancreatic cancer. His work exemplifies the impact of innovation in the medical field, paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile